Bridge City Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Bridge City Capital’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-54,314	Closed	-$1.06M	–	97
2018 Q1	$1.06M	Buy	54,314 +3,028	+6%	+$59.4K	0.71%	75
2017 Q4	$854K	Hold	51,286	–	–	0.62%	82
2017 Q3	$1.04M	Buy	51,286 +4,092	+9%	+$78.2K	0.78%	69
2017 Q2	$760K	Buy	+47,194	New	+$697K	0.63%	80

Bridge City Capital's IPXL Position: Q2 2018 in Review

Bridge City Capital sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 54,314 shares — an estimated $1.06M sold.

Bridge City Capital first reported a position in IPXL in Q2 2017 and held it in 4 quarters. The position peaked at $1.06M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Bridge City Capital reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Bridge City Capital sold 54,314 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1.06M.
Bridge City Capital first reported a position in Impax Laboratories, Inc. in Q2 2017 and held it in 4 quarters.
Bridge City Capital's Impax Laboratories, Inc. position peaked at $1.06M in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Bridge City Capital's 13F filing for Q2 2018, filed 23 Jul 2018.